GERN - Director at Geron Acquires Company Stock Options Worth 200000 Shares | Benzinga
Guarav Aggarwal, Director at Geron (NASDAQ:GERN), reported a large acquisition of company stock options on November 28, according to a new SEC filing.
What Happened: A Form 4 filing from the U.S. Securities and Exchange Commission on Tuesday showed that Aggarwal, Director at Geron, a company in the Health Care sector, was just awarded stock options worth 200,000 shares of GERN. The options give Aggarwal the right to buy the company's stock at $1.97 per share.
Geron shares are trading up 3.14% at $1.97 at the time of this writing on Wednesday morning. Since the current price is $1.97, this makes Aggarwal's 200,000 shares worth $393,980.